RT Journal Article
SR Electronic
T1 delta 9-Tetrahydrocannabinol decreases turnover of brain histamine.
JF Journal of Pharmacology and Experimental Therapeutics
JO J Pharmacol Exp Ther
FD American Society for Pharmacology and Experimental Therapeutics
SP 513
OP 518
VO 232
IS 2
A1 R Oishi
A1 Y Itoh
A1 M Nishibori
A1 K Saeki
YR 1985
UL http://jpet.aspetjournals.org/content/232/2/513.abstract
AB Histamine (HA) is a neurotransmitter present in the brain. As there is little information on the effect of delta 9-tetrahydrocannabinol (delta 9-THC) on brain histaminergic activity, the possible delta 9-THC-induced changes in brain HA turnover were studied in rats and mice. Whereas various doses of delta 9-THC had no influence on the brain HA levels in these species, high doses of delta 9-THC reduced the content of tele-methylhistamine (t-MH), a predominant HA metabolite in the brain, in mice. A moderate dose of delta 9-THC was effective in decreasing the brain t-MH content in the rats. Pargyline (65 mg/kg i.p.) caused a 101 ng/g accumulation of t-MH in mice and an 80 ng/g accumulation of t-MH in rats 105 min after the injection. delta 9-THC significantly suppressed the pargyline-induced t-MH accumulation at 50 mg/kg in mice whereas only 2 mg/kg of this compound was effective in rats, when administered i.v. 15 min after pargyline treatment. delta 9-THC (50 mg/kg i.v.) delayed the depletion of neuronal HA in the mouse brain, as induced by treatment with a specific histidine decarboxylase inhibitor alpha-fluoromethylhistidine (50 mg/kg i.p.). delta 9-THC (30 and 100 microM) significantly inhibited the K+-induced release of endogenous HA from guinea-pig hypothalamic slices. These results suggest that delta 9-THC decreases HA turnover in the brain.